{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:31:10Z","timestamp":1768365070188,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-03034-9","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T13:06:08Z","timestamp":1765112768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological characteristics of hepatitis B virus infection in adult patients before, during and after COVID-19 in China"],"prefix":"10.1186","volume":"23","author":[{"given":"Hao","family":"Dang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"issue":"10381","key":"3034_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/s0140-6736(22)01468-4","volume":"25","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF. Hepatitis B. Lancet. 2023;25(10381):1039\u201352. https:\/\/doi.org\/10.1016\/s0140-6736(22)01468-4.","journal-title":"Lancet"},{"issue":"8","key":"3034_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524\u201337. https:\/\/doi.org\/10.1038\/s41575-023-00760-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3034_CR3","unstructured":"Organization WH. Global hepatitis report 2024: Action for access in low- and middle-income countries. 2024."},{"key":"3034_CR4","unstructured":"Organization WH. Hepatitis. 07\/12, 2023. Accessed 07\/12, 2023. https:\/\/www.who.int\/china\/health-topics\/hepatitis"},{"key":"3034_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002306","author":"S Chen","year":"2020","unstructured":"Chen S, Mao W, Guo L, Zhang J, Tang S. Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China. BMJ Glob Health. 2020. https:\/\/doi.org\/10.1136\/bmjgh-2020-002306.","journal-title":"BMJ Glob Health"},{"issue":"10","key":"3034_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"D Razavi-Shearer","year":"2023","unstructured":"Razavi-Shearer D, Gamkrelidze I, Pan C, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907. https:\/\/doi.org\/10.1016\/S2468-1253(23)00197-8.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"3034_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/blt.18.219469","volume":"1","author":"J Liu","year":"2019","unstructured":"Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating hepatitis B disease, China. Bull World Health Organ. 2019;1(3):230\u20138. https:\/\/doi.org\/10.2471\/blt.18.219469.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"3034_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41579-022-00807-9","volume":"21","author":"EJ Chow","year":"2023","unstructured":"Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023;21(3):195\u2013210. https:\/\/doi.org\/10.1038\/s41579-022-00807-9.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"3034_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2219577","volume":"19","author":"E Hamson","year":"2023","unstructured":"Hamson E, Forbes C, Wittkopf P, et al. Impact of pandemics and disruptions to vaccination on infectious diseases epidemiology past and present. Hum Vaccin Immunother. 2023;19(2):2219577. https:\/\/doi.org\/10.1080\/21645515.2023.2219577.","journal-title":"Hum Vaccin Immunother"},{"key":"3034_CR10","doi-asserted-by":"publisher","unstructured":"Meyer Sauteur PM, Beeton ML. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe Nov. 2023;23. https:\/\/doi.org\/10.1016\/s2666-5247(23)00344-0.","DOI":"10.1016\/s2666-5247(23)00344-0"},{"issue":"3","key":"3034_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jinf.2021.06.018","volume":"83","author":"A Mendez-Brito","year":"2021","unstructured":"Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. J Infect. 2021;83(3):281\u201393. https:\/\/doi.org\/10.1016\/j.jinf.2021.06.018.","journal-title":"J Infect"},{"issue":"1","key":"3034_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11111-1","volume":"21","author":"I Ayouni","year":"2021","unstructured":"Ayouni I, Maatoug J, Dhouib W, et al. Effective public health measures to mitigate the spread of COVID-19: a systematic review. BMC Public Health. 2021;21(1):1015. https:\/\/doi.org\/10.1186\/s12889-021-11111-1.","journal-title":"BMC Public Health"},{"key":"3034_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100282","volume":"17","author":"J Xiao","year":"2021","unstructured":"Xiao J, Dai J, Hu J, et al. Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: a large population-based observational study. The Lancet Regional Health - Western Pacific. 2021;17:100282. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100282.","journal-title":"The Lancet Regional Health - Western Pacific"},{"issue":"1","key":"3034_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/epidemiologia3010009","volume":"3","author":"F Borre","year":"2022","unstructured":"Borre F, Borri JI, Cohen YZ, Gasparoto M, Gurung TB. Impact of the COVID-19 pandemic on infectious diseases in Brazil: a case study on dengue infections. Epidemiologia. 2022;3(1):97\u2013115. https:\/\/doi.org\/10.3390\/epidemiologia3010009.","journal-title":"Epidemiologia"},{"key":"3034_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijid.2023.01.013","volume":"128","author":"K Hirae","year":"2023","unstructured":"Hirae K, Hoshina T, Koga H. Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan. Int J Infect Dis. 2023;128:265\u201371. https:\/\/doi.org\/10.1016\/j.ijid.2023.01.013.","journal-title":"Int J Infect Dis"},{"issue":"13","key":"3034_CR16","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.3201\/eid2813.212300","volume":"28","author":"HJ Kabore","year":"2022","unstructured":"Kabore HJ, Li X, Allison RD, et al. Effects of decreased immunization coverage for hepatitis B virus caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020. Emerg Infect Dis. 2022;28(13):S217-s224. https:\/\/doi.org\/10.3201\/eid2813.212300.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"3034_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/cid\/ciac100","volume":"75","author":"S Perniciaro","year":"2022","unstructured":"Perniciaro S, van der Linden M, Weinberger DM. Reemergence of invasive pneumococcal disease in Germany during the spring and summer of 2021. Clin Infect Dis. 2022;75(7):1149\u201353. https:\/\/doi.org\/10.1093\/cid\/ciac100.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3034_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2021.100802","volume":"40","author":"R Piarroux","year":"2021","unstructured":"Piarroux R, Gaudart J, Rebaudet S. COVID-19 pandemic: the story is not over yet. Anaesthesia Critical Care & Pain Medicine. 2021;40(1):100802. https:\/\/doi.org\/10.1016\/j.accpm.2021.100802.","journal-title":"Anaesthesia Critical Care & Pain Medicine"},{"issue":"9","key":"3034_CR19","doi-asserted-by":"publisher","first-page":"e701","DOI":"10.1016\/s2468-2667(23)00149-4","volume":"8","author":"B Hepatitis","year":"2023","unstructured":"Hepatitis B. Europe: an update from the global burden of disease study 2019. Lancet Public Health Sep. 2023;8(9):e701\u201316. https:\/\/doi.org\/10.1016\/s2468-2667(23)00149-4.","journal-title":"Lancet Public Health Sep"},{"key":"3034_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004275","author":"CM Pley","year":"2021","unstructured":"Pley CM, McNaughton AL, Matthews PC, Louren\u00e7o J. The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. BMJ Glob Health. 2021. https:\/\/doi.org\/10.1136\/bmjgh-2020-004275.","journal-title":"BMJ Glob Health"},{"key":"3034_CR21","doi-asserted-by":"publisher","first-page":"1171516","DOI":"10.3389\/fpubh.2023.1171516","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, Xie N, Li F, et al. Spatial age-period-cohort analysis of hepatitis B risk in Xinjiang from 2006 to 2019. Front Public Health. 2023;11:1171516. https:\/\/doi.org\/10.3389\/fpubh.2023.1171516.","journal-title":"Front Public Health"},{"issue":"2","key":"3034_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/15321819.2023.2168555","volume":"44","author":"F Osei-Boakye","year":"2023","unstructured":"Osei-Boakye F, Nkansah C, Appiah SK, et al. Seroprevalence, trends, and risk factors of hepatitis B and C among family replacement blood donors; a 7-year retrospective study at Sunyani Municipal Hospital, Ghana. J Immunoassay Immunochem. 2023;44(2):162\u201375. https:\/\/doi.org\/10.1080\/15321819.2023.2168555.","journal-title":"J Immunoassay Immunochem"},{"issue":"3","key":"3034_CR23","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/jmv.26446","volume":"93","author":"J Bouayed","year":"2021","unstructured":"Bouayed J, Bohn T. Behavioral manipulation-key to the successful global spread of the new coronavirus SARS-CoV-2? J Med Virol Mar. 2021;93(3):1748\u201351. https:\/\/doi.org\/10.1002\/jmv.26446.","journal-title":"J Med Virol Mar"},{"key":"3034_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101724118","author":"O Sullivan","year":"2021","unstructured":"Sullivan O, Gershuny J, Sevilla A, et al. Using time-use diaries to track changing behavior across successive stages of COVID-19 social restrictions. Proc Natl Acad Sci USA. 2021. https:\/\/doi.org\/10.1073\/pnas.2101724118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3034_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05359-y","volume":"20","author":"A Scheibe","year":"2020","unstructured":"Scheibe A, Young K, Versfeld A, et al. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). BMC Infect Dis. 2020;20(1):655. https:\/\/doi.org\/10.1186\/s12879-020-05359-y.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"3034_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/sextrans-2020-054768","volume":"97","author":"I Hyndman","year":"2021","unstructured":"Hyndman I, Nugent D, Whitlock GG, McOwan A, Girometti N. COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK. Sex Transm Infect. 2021;97(7):521\u20134. https:\/\/doi.org\/10.1136\/sextrans-2020-054768.","journal-title":"Sex Transm Infect"},{"issue":"8","key":"3034_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad399","volume":"10","author":"C Mugglin","year":"2023","unstructured":"Mugglin C, Hamusonde K, Salazar-Vizcaya L. Sexual behaviour and STI incidence in sexually active MSM living with HIV in times of COVID-19. Open Forum Infect Dis. 2023;10(8):ofad399. https:\/\/doi.org\/10.1093\/ofid\/ofad399.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"3034_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/s2468-1253(20)30155-2","volume":"5","author":"N Gupta","year":"2020","unstructured":"Gupta N, Desalegn H, Ocama P. Converging pandemics: implications of COVID-19 for the viral hepatitis response in sub-Saharan Africa. Lancet Gastroenterol Hepatol. 2020;5(7):634\u20136. https:\/\/doi.org\/10.1016\/s2468-1253(20)30155-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3034_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11070816","author":"C Sagnelli","year":"2022","unstructured":"Sagnelli C, Montella L, Grimaldi P, et al. COVID-19 as another trigger for HBV reactivation: clinical case and review of literature. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11070816.","journal-title":"Pathogens"},{"issue":"2","key":"3034_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12072-022-10306-x","volume":"16","author":"TC Yip","year":"2022","unstructured":"Yip TC, Gill M, Wong GL, Liu K. Management of hepatitis B virus reactivation due to treatment of COVID-19. Hepatol Int. 2022;16(2):257\u201368. https:\/\/doi.org\/10.1007\/s12072-022-10306-x.","journal-title":"Hepatol Int"},{"issue":"6","key":"3034_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10096-023-04599-5","volume":"42","author":"H Foo","year":"2023","unstructured":"Foo H, Phan F, Bagatella M. Risk of hepatitis B reactivation following baricitinib or tocilizumab for treatment of COVID-19. Eur J Clin Microbiol Infect Dis. 2023;42(6):799\u2013801. https:\/\/doi.org\/10.1007\/s10096-023-04599-5.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"3034_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28452","volume":"95","author":"G Suda","year":"2023","unstructured":"Suda G, Baba M, Yamamoto Y. Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation\u2010related hepatitis. J Med Virol. 2023;95(2):e28452. https:\/\/doi.org\/10.1002\/jmv.28452.","journal-title":"J Med Virol"},{"issue":"3","key":"3034_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/s2468-1253(16)30031-0","volume":"1","author":"S Wait","year":"2016","unstructured":"Wait S, Kell E, Hamid S, et al. Hepatitis B and hepatitis C in Southeast and Southern asia: challenges for governments. Lancet Gastroenterol Hepatol. 2016;1(3):248\u201355. https:\/\/doi.org\/10.1016\/s2468-1253(16)30031-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"3034_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1950504","volume":"18","author":"K Kricorian","year":"2022","unstructured":"Kricorian K, Civen R, Equils O. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety. Hum Vaccin Immunother. 2022;18(1):1950504. https:\/\/doi.org\/10.1080\/21645515.2021.1950504.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"3034_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41591-023-02241-7","volume":"29","author":"G Wang","year":"2023","unstructured":"Wang G, Yao Y, Wang Y, et al. Determinants of COVID-19 vaccination status and hesitancy among older adults in China. Nat Med. 2023;29(3):623\u201331. https:\/\/doi.org\/10.1038\/s41591-023-02241-7.","journal-title":"Nat Med"},{"issue":"11","key":"3034_CR36","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1136\/gutjnl-2021-326792","volume":"71","author":"JF Dufour","year":"2022","unstructured":"Dufour JF, Marjot T, Becchetti C, Tilg H. COVID-19 and liver disease. Gut. 2022;71(11):2350\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2021-326792.","journal-title":"Gut"},{"key":"3034_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110439","volume":"121","author":"MT Imam","year":"2023","unstructured":"Imam MT, Almalki ZS, Alzahrani AR, et al. COVID-19 and severity of liver diseases: possible crosstalk and clinical implications. Int Immunopharmacol. 2023;121:110439. https:\/\/doi.org\/10.1016\/j.intimp.2023.110439.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"3034_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3748\/wjg.v29.i5.815","volume":"29","author":"I Vuj\u010di\u0107","year":"2023","unstructured":"Vuj\u010di\u0107 I. Outcomes of COVID-19 among patients with liver disease. World J Gastroenterol. 2023;29(5):815\u201324. https:\/\/doi.org\/10.3748\/wjg.v29.i5.815.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3034_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15268-9","volume":"23","author":"L Wang","year":"2023","unstructured":"Wang L, Zhao N, Wang Y, et al. Impact of the COVID-19 pandemic and the dynamic COVID-zero strategy on HIV incidence and mortality in China. BMC Public Health. 2023;23(1):361. https:\/\/doi.org\/10.1186\/s12889-023-15268-9.","journal-title":"BMC Public Health"},{"issue":"1","key":"3034_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29374","volume":"96","author":"L Hu","year":"2024","unstructured":"Hu L, Yang Y, Lin J, et al. Epidemiological characteristics of respiratory syncytial virus infection in pediatric patients before, during the COVID-19 pandemic and after easing of COVID-19 restrictive measures in China. J Med Virol. 2024;96(1):e29374. https:\/\/doi.org\/10.1002\/jmv.29374.","journal-title":"J Med Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-03034-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:04:41Z","timestamp":1768341881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-025-03034-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3034"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-03034-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"was granted by the ethics committee of the Third Hospital of Mianyang (Sichuan Mental Health Center) (No. 2023-IRB-50).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}